News

Sun Pharma Announces FDA Approval of Next Generation BLU-U® Blue Light Photodynamic Therapy Illuminator for Actinic Keratosis
"We are pleased to receive the FDA's approval of LED BLU-U and look forward to seeing the positive impact this next ...
Morningstar5d
Sun Pharma Announces FDA Approval of Next Generation BLU-U® Blue Light Photodynamic Therapy Illuminator for Actinic Keratosis
About LEVULAN KERASTICK + BLU-U LEVULAN KERASTICK + BLU-U blue light is the only FDA-approved photodynamic therapy (PDT) that effectively targets and clears actinic keratosis (AK) on the face ...
Sun Pharma shares in focus after USFDA nod for next-gen skin disorder device
The company announced that the USFDA has approved its enhanced PDT system through the agencys Real-Time Review Program. This ...
Capital Market on MSN2d
Sun Pharma rises after USFDA approves next-gen Blue Light PDT device for actinic keratosis
The new model (LED BLU-U) in combination with LEVULAN KERASTICK (aminolevulinic acid HCl) topical solution, 20%, is indicated for the treatment of minimally to moderately thick actinic keratoses (AK) ...